This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsRadient Technologies（RD8）株式概要Engages in the cannabinoids business in Canada. 詳細RD8 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析過去5年間で収益は年間2.8%減少しました。 マイナスの株主資本 意味のある時価総額がありません ( €2M )キャッシュランウェイが1年未満である +2 さらなるリスクすべてのリスクチェックを見るRD8 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.000596.4% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-39m13m2016201920222025202620282031Revenue CA$6.4mEarnings CA$937.8kAdvancedSet Fair ValueView all narrativesRadient Technologies Inc. 競合他社BiofronteraSymbol: XTRA:B8FKMarket cap: €14.7mApontis PharmaSymbol: XTRA:APPHMarket cap: €91.6mSynBioticSymbol: DUSE:SBXMarket cap: €15.2mMPH Health CareSymbol: DB:93M1Market cap: €113.5m価格と性能株価の高値、安値、推移の概要Radient Technologies過去の株価現在の株価CA$0.000552週高値CA$0.02152週安値CA$0.0005ベータ0.881ヶ月の変化0%3ヶ月変化0%1年変化-97.56%3年間の変化-99.44%5年間の変化-99.95%IPOからの変化-99.83%最新ニュースお知らせ • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).お知らせ • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.お知らせ • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.最新情報をもっと見るRecent updatesお知らせ • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).お知らせ • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.お知らせ • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 02Radient Technologies Inc. Announces Board ChangesRadient Technologies Inc. announced the appointments of Jocelyne Lafreniere, a long-time director, as the chairperson of the Board and Danesh Varma as a director of the Company. Ms. Lafreniere's appointment is effective immediately and follows the resignation of Francesco Ferlaino as a director and the chairperson of the Board. Mr. Varma's appointment will be effective upon satisfactory security clearance by Health Canada. Danesh Varma established himself in the Canadian business community as a senior audit manager with Deloitte's in Canada. In addition, he has served with reporting issuers, both as CFO and as a Director in both Canada and the United States, for companies such as Labrador Iron Mines Holdings and Brookfield Investment Corporation. Now a U.K. resident, Mr. Varma is active in the investment and private equity fields.お知らせ • Jun 19Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a best efforts non-brokered private placement financing of up to 30 units at a price of CAD 40,000 per unit for gross proceeds of up to CAD 1,200,000 on June 17, 2022. Each unit shall consist of 1,000,000 common shares of the company and 500,000 common share purchase warrants with each warrant entitling the holder to purchase one common share of the company at CAD 0.07 per share for 36 months following the closing of the transaction subject to early expiry if, commencing four months after the closing of the transaction, the common shares of the company trade at a volume weighted average trading price of CAD 0.15 or higher for a period of 20 consecutive days. The transaction is expected to close on June 30, 2022. Finder's fees may be paid to eligible finders in accordance with the policies of the TSX Venture Exchange. All securities issued in connection with the transaction will be subject to a statutory hold period of four months and one day. Completion of the transaction is subject to certain conditions, including TSXV approval.お知らせ • Apr 06Radient Technologies Inc. announced that it expects to receive CAD 9.93 million in funding from Moskowitz Capital Mortgage Fund II Inc.Radient Technologies Inc. announced that it will receive CAD 9,930,000 in a round of funding on April 4, 2022. The company will issue loans with warrants in the transaction. The transaction includes participation from Moskowitz Capital Mortgage Fund II Inc. The company will issue 10,000,000 non-transferable common share purchase warrants, each warrant entitling to purchase one common share of the company at an exercise price of CAD 0.085 for one year following the date of issuance. No finder's fees are payable in connection with the amendment. All securities issued in connection with the amendment will be subject to a statutory hold period expiring four months and one day following the issuance date of the warrants. The issuance of the warrants is subject to the approval of the TSX Venture Exchange.Reported Earnings • Mar 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.007 loss per share (up from CA$0.034 loss in 3Q 2021). Revenue: CA$1.58m (down 13% from 3Q 2021). Net loss: CA$3.20m (loss narrowed 72% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Jan 30Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. for $8.075 million.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $6.8 million on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of CAD 0.12 per share, for an aggregate deemed value of CAD 6 million; 15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares for CAD 0.15 for a period of 24 months following closing; 30 million common share purchase warrants, with each warrant entitling the holder thereof to acquire one common share for CAD 0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following closing. Radient will also pay 2% royalty on all gross sales of TRX products. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021. As of October 6, 2021, the transaction is expected to close by October 30, 2021. As of November 29, 2021, Radient Technologies signed Definitive Agreement to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $8.075 million. Pursuant to the Definitive Agreement, Radient will acquire Tunaaaa for 70 million common shares of Radient priced at CAD 0.12 per share and 15 million warrants of Radient exercisable at a price of CAD 0.15 per share for a period of two years following the closing of the Acquisition, and up to 25 million common shares of Radient at a deemed price of CAD 0.12 per share issued contingently upon certain revenue performance milestone achievements following the closing of the Acquisition. Radient will also pay 4% royalty on all gross sales of TRX products if the revenue is greater than $0.5 million in a month. As of November 29, 2021, the transaction is expected to close prior to December 31, 2021. As of January 6, 2022 Tunaaaa Room Inc. was replaced as a shareholder and vendor of the Target by its two shareholders. Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. on January 28, 2022. Radient will pay 1% royalty on all gross sales of TRX products.Recent Insider Transactions • Jan 15Chief Financial Officer recently bought €149k worth of stockOn the 11th of January, Prakash Hariharan bought around 4m shares on-market at roughly €0.042 per share. This was the largest purchase by an insider in the last 3 months. Prakash has been a buyer over the last 12 months, purchasing a net total of €197k worth in shares.お知らせ • Dec 16Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.06 per unit for gross proceeds of up to CAD 1,200,000 on December 15, 2021. Each unit will consist of one common share of the company and one common share purchase warrant, with each warrant entitling the holder to purchase one common share of the company at CAD 0.10 per share for a period of 18 months following the closing date of the offering. The offering is expected to close on or about December 31, 2021. The company may pay finder's fees in cash of up to 7% of gross proceeds of the offering and finder's warrants in an amount of up to 7% of the units sold pursuant to the offering to eligible finders in accordance with the policies of the TSX Venture Exchange. Each finder warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.10 for a period of 18 months following the closing date of the offering. All securities issued by the company in connection with the offering will be subject to a statutory hold period of four months and one day. Completion of the offering is subject to certain conditions, including TSX Venture Exchange approval.Reported Earnings • Nov 30Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: CA$0.004 loss per share (up from CA$0.011 loss in 2Q 2021). Revenue: CA$1.10m (up CA$994.4k from 2Q 2021). Net loss: CA$1.64m (loss narrowed 52% from 2Q 2021). Revenue was in line with analyst estimates.Reported Earnings • Oct 03Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.14 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: CA$2.49m (down 87% from FY 2020). Net loss: CA$42.3m (loss widened 13% from FY 2020).お知らせ • Jul 02Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of $0.12 per share, for an aggregate deemed value of $6 million;15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares (each, a "Common Share") for $0.15 for a period of 24 months following Closing; 30 million Common Share purchase warrants, with each warrant entitling the holder thereof to acquire one Common Share for $0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following Closing. Radient will also pay 2% of all gross sales of TRX products. The executive team of Tunaaaa Room shall be required to work for the benefit of Radient to develop new terpene blends and launch new products and brands, and provide exclusive cannabis-growing management services to Radient. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021.お知らせ • Mar 17Radient Technologies Inc. announced that it has received CAD 2.9955 million in fundingOn March 15, 2021, Radient Technologies Inc. (TSXV:RTI) closed the transaction. The company issued 13,425,000 shares for gross proceeds of CAD 13,425,000 in its third and final tranche. The company has raised CAD 2,995,500 in funding so far in the transaction. The transaction included participation from 40 placees including Steven Splinter for 250,000 shares, Yves Gougoux for 500,000 shares, Jan Pretzel for 500,000 shares, Jocelyne Lafreniere for 500,000 shares, Francesco Ferlaino for 750,000 shares, and Prakash Hariharan for 650,000 shares. The company paid a finders' fees of CAD 175,190 with respect to the transaction, CAD 102,600 to Michael Sobolewski, CAD 49,840 to HB Investments & Finance AG, and CAD 22,750 to Cannacord Genuity Corp.Reported Earnings • Mar 02Third quarter 2021 earnings released: CA$0.034 loss per share (vs CA$0.02 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: CA$1.81m (down 84% from 3Q 2020). Net loss: CA$11.2m (loss widened 106% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.お知らせ • Feb 05Radient Technologies Inc. Announces Executive ChangesRadient Technologies Inc. announced the appointment of Harry Kaura as the CEO of the Company effective Feb. 03, 2021. Harry is an Edmonton based hands on entrepreneur, with vast experience in operations and business development through his firm Amnor Corporation. He has over three decades of experience as a hands-on operator and fully capable to lead Radient into its new path as a profitable operating business. As Harry has served as a Director in Radient's Board since 2013 and dedicated the past five months in the Business Development initiatives and the management of the operations for Radient. He led the team in Radient in the reorganization of the manufacturing unit that is in full ramp up mode since January 2021. While Jan Petzel will hand over his role as interim CEO of Radient, he will continue to serve the business in an active advisory role to in support Harry Kaura and the team. Jan has been instrumental in leading the transformation of the Company towards a path to operating profitability in calendar 2021.Reported Earnings • Dec 02Second quarter 2021 earnings released: CA$0.011 loss per shareThe company reported a soft second quarter result with weaker revenues and control over expenses, though losses reduced. Second quarter 2021 results: Revenue: CA$102.7k (down 92% from 2Q 2020). Net loss: CA$3.41m (loss narrowed 51% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 65% per year, which means it is performing significantly worse than earnings.お知らせ • Nov 28Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis ProductsRadient Technologies Inc. announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences. A human sensory panel is an extremely valuable tool to include in product development and quality programs. It will now form an integral part of Radient's R&D and product development and innovation activities by including the ability to evaluate cannabis extracts, concentrates, edibles and topicals for reactions of human subjects to the smell, sight, taste and touch at the product development stage. This new tool will improve the inherent quality of cannabis product offerings by complementing the stringent internal manufacturing quality systems currently in place, ensuring that all products continue to meet consumers' expectations. This is in addition to Radient's proprietary MAP continuous extraction process that has proven to generate high recoveries (> 95%) of active compounds from the cannabis plant.お知らせ • Nov 26Radient Technologies Announces Partnership with Dreamy CBDRadient Technologies Inc. announced a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with a positive lifestyle in the rapidly growing Wellness space. The Dreamy CBD products comprise CBD tinctures, CBD distillates, CBD edibles, CBD cosmetics, and CBD Vape Cartridges geared towards the recreational and medical cannabis market. Under this partnership, Radient will have exclusive rights to the licenses and trademarks for Dreamy CBD brands and will collaborate jointly with Dreamy to produce their CBD products and launch their brands in Canada. Radient will be involved in providing the processing facilities in Edmonton and the necessary infrastructure to extract CBD products for Dreamy CBD. In addition, through its Sales License and associated registrations in the provinces, Radient will look to build the Dreamy CBD product portfolio in Canada. On the international front, Radient will produce their CBD based products for markets in Thailand and Japan that are witnessing a strong surge in CBD products consumption, especially in the Wellness space. This will be after completing a comprehensive review of the trade requirements with local partners in these jurisdictions. The partnership is being set initially for a two-year term with an annual renewable option, with Radient reserving the right of first refusal to acquire Dreamy.Reported Earnings • Oct 10First quarter earnings releasedOver the last 12 months the company has reported total losses of CA$36.5m, with losses widening by 19% from the prior year. Total revenue was CA$18.4m over the last 12 months, up by CA$18.2m from the prior year.お知らせ • Sep 19+ 1 more updateRadient Technologies Inc. Announces Management ChangesThe board of Radient Technologies Inc. named Jan Petzel as Interim President, effective immediately. Mr. Petzel has been a Director of the Radient since 2016 and has a comprehensive understanding of the company, and a pragmatic view of the priorities that need to be addressed. Jan was a managing director in the Merchant Banking Division of Goldman Sachs, ultimately responsible for private credit in Germany and Scandinavia. While at Goldman Sachs, Mr. Petzel served on the board of several successful companies including Cognis GmbH, a worldwide supplier of specialty chemicals and nutritional ingredients, up to its sale to BASF for €3.1 billion in 2010. The company also announced that Denis Taschuk will step down as president and director of the company, effectively immediately, for family reasons. He will continue as advisor to the Board to facilitate the transition to a new chief executive officer. Denis has been instrumental in leading Radient to become a significant company in the cannabis industry, and the Board wishes to thank Denis for his contribution and tireless efforts over the last 10 years. The company also announced that Mike Cabigon will step down as chief operating officer and director of the company, effective immediately, to pursue other interests. Mike was instrumental in the company’s pivot into the cannabis industry in 2016, and the Board thanks him for all his contribution over the years and wishes him well in his future endeavors.お知らせ • Sep 17Radient Technologies Inc. Auditor Raises 'Going Concern' DoubtRadient Technologies Inc. filed its Annual on Sep 14, 2020 for the period ending Mar 31, 2020. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.株主還元RD8DE PharmaceuticalsDE 市場7D0%3.4%0.6%1Y-97.6%26.6%0.2%株主還元を見る業界別リターン: RD8過去 1 年間で26.6 % の収益を上げたGerman Pharmaceuticals業界を下回りました。リターン対市場: RD8は、過去 1 年間で0.2 % のリターンを上げたGerman市場を下回りました。価格変動Is RD8's price volatile compared to industry and market?RD8 volatilityRD8 Average Weekly Movementn/aPharmaceuticals Industry Average Movement6.3%Market Average Movement6.1%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: RD8の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のRD8のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aSteven Splinterwww.radientinc.comもっと見るRadient Technologies Inc. 基礎のまとめRadient Technologies の収益と売上を時価総額と比較するとどうか。RD8 基礎統計学時価総額€1.88m収益（TTM）-€7.86m売上高(TTM)€2.19m0.9xP/Sレシオ-0.2xPER（株価収益率RD8 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計RD8 損益計算書（TTM）収益CA$3.15m売上原価CA$3.87m売上総利益-CA$718.42kその他の費用CA$10.58m収益-CA$11.30m直近の収益報告Dec 31, 2022次回決算日該当なし一株当たり利益（EPS）-0.021グロス・マージン-22.82%純利益率-359.00%有利子負債／自己資本比率-80.4%RD8 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/06/05 20:32終値2023/03/08 00:00収益2022/12/31年間収益2022/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Radient Technologies Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.
Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).
お知らせ • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.
お知らせ • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.
Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).
Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.
Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).
お知らせ • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.
お知らせ • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.
Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).
Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 02Radient Technologies Inc. Announces Board ChangesRadient Technologies Inc. announced the appointments of Jocelyne Lafreniere, a long-time director, as the chairperson of the Board and Danesh Varma as a director of the Company. Ms. Lafreniere's appointment is effective immediately and follows the resignation of Francesco Ferlaino as a director and the chairperson of the Board. Mr. Varma's appointment will be effective upon satisfactory security clearance by Health Canada. Danesh Varma established himself in the Canadian business community as a senior audit manager with Deloitte's in Canada. In addition, he has served with reporting issuers, both as CFO and as a Director in both Canada and the United States, for companies such as Labrador Iron Mines Holdings and Brookfield Investment Corporation. Now a U.K. resident, Mr. Varma is active in the investment and private equity fields.
お知らせ • Jun 19Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a best efforts non-brokered private placement financing of up to 30 units at a price of CAD 40,000 per unit for gross proceeds of up to CAD 1,200,000 on June 17, 2022. Each unit shall consist of 1,000,000 common shares of the company and 500,000 common share purchase warrants with each warrant entitling the holder to purchase one common share of the company at CAD 0.07 per share for 36 months following the closing of the transaction subject to early expiry if, commencing four months after the closing of the transaction, the common shares of the company trade at a volume weighted average trading price of CAD 0.15 or higher for a period of 20 consecutive days. The transaction is expected to close on June 30, 2022. Finder's fees may be paid to eligible finders in accordance with the policies of the TSX Venture Exchange. All securities issued in connection with the transaction will be subject to a statutory hold period of four months and one day. Completion of the transaction is subject to certain conditions, including TSXV approval.
お知らせ • Apr 06Radient Technologies Inc. announced that it expects to receive CAD 9.93 million in funding from Moskowitz Capital Mortgage Fund II Inc.Radient Technologies Inc. announced that it will receive CAD 9,930,000 in a round of funding on April 4, 2022. The company will issue loans with warrants in the transaction. The transaction includes participation from Moskowitz Capital Mortgage Fund II Inc. The company will issue 10,000,000 non-transferable common share purchase warrants, each warrant entitling to purchase one common share of the company at an exercise price of CAD 0.085 for one year following the date of issuance. No finder's fees are payable in connection with the amendment. All securities issued in connection with the amendment will be subject to a statutory hold period expiring four months and one day following the issuance date of the warrants. The issuance of the warrants is subject to the approval of the TSX Venture Exchange.
Reported Earnings • Mar 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.007 loss per share (up from CA$0.034 loss in 3Q 2021). Revenue: CA$1.58m (down 13% from 3Q 2021). Net loss: CA$3.20m (loss narrowed 72% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 30Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. for $8.075 million.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $6.8 million on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of CAD 0.12 per share, for an aggregate deemed value of CAD 6 million; 15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares for CAD 0.15 for a period of 24 months following closing; 30 million common share purchase warrants, with each warrant entitling the holder thereof to acquire one common share for CAD 0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following closing. Radient will also pay 2% royalty on all gross sales of TRX products. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021. As of October 6, 2021, the transaction is expected to close by October 30, 2021. As of November 29, 2021, Radient Technologies signed Definitive Agreement to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $8.075 million. Pursuant to the Definitive Agreement, Radient will acquire Tunaaaa for 70 million common shares of Radient priced at CAD 0.12 per share and 15 million warrants of Radient exercisable at a price of CAD 0.15 per share for a period of two years following the closing of the Acquisition, and up to 25 million common shares of Radient at a deemed price of CAD 0.12 per share issued contingently upon certain revenue performance milestone achievements following the closing of the Acquisition. Radient will also pay 4% royalty on all gross sales of TRX products if the revenue is greater than $0.5 million in a month. As of November 29, 2021, the transaction is expected to close prior to December 31, 2021. As of January 6, 2022 Tunaaaa Room Inc. was replaced as a shareholder and vendor of the Target by its two shareholders. Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. on January 28, 2022. Radient will pay 1% royalty on all gross sales of TRX products.
Recent Insider Transactions • Jan 15Chief Financial Officer recently bought €149k worth of stockOn the 11th of January, Prakash Hariharan bought around 4m shares on-market at roughly €0.042 per share. This was the largest purchase by an insider in the last 3 months. Prakash has been a buyer over the last 12 months, purchasing a net total of €197k worth in shares.
お知らせ • Dec 16Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.06 per unit for gross proceeds of up to CAD 1,200,000 on December 15, 2021. Each unit will consist of one common share of the company and one common share purchase warrant, with each warrant entitling the holder to purchase one common share of the company at CAD 0.10 per share for a period of 18 months following the closing date of the offering. The offering is expected to close on or about December 31, 2021. The company may pay finder's fees in cash of up to 7% of gross proceeds of the offering and finder's warrants in an amount of up to 7% of the units sold pursuant to the offering to eligible finders in accordance with the policies of the TSX Venture Exchange. Each finder warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.10 for a period of 18 months following the closing date of the offering. All securities issued by the company in connection with the offering will be subject to a statutory hold period of four months and one day. Completion of the offering is subject to certain conditions, including TSX Venture Exchange approval.
Reported Earnings • Nov 30Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: CA$0.004 loss per share (up from CA$0.011 loss in 2Q 2021). Revenue: CA$1.10m (up CA$994.4k from 2Q 2021). Net loss: CA$1.64m (loss narrowed 52% from 2Q 2021). Revenue was in line with analyst estimates.
Reported Earnings • Oct 03Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.14 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: CA$2.49m (down 87% from FY 2020). Net loss: CA$42.3m (loss widened 13% from FY 2020).
お知らせ • Jul 02Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of $0.12 per share, for an aggregate deemed value of $6 million;15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares (each, a "Common Share") for $0.15 for a period of 24 months following Closing; 30 million Common Share purchase warrants, with each warrant entitling the holder thereof to acquire one Common Share for $0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following Closing. Radient will also pay 2% of all gross sales of TRX products. The executive team of Tunaaaa Room shall be required to work for the benefit of Radient to develop new terpene blends and launch new products and brands, and provide exclusive cannabis-growing management services to Radient. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021.
お知らせ • Mar 17Radient Technologies Inc. announced that it has received CAD 2.9955 million in fundingOn March 15, 2021, Radient Technologies Inc. (TSXV:RTI) closed the transaction. The company issued 13,425,000 shares for gross proceeds of CAD 13,425,000 in its third and final tranche. The company has raised CAD 2,995,500 in funding so far in the transaction. The transaction included participation from 40 placees including Steven Splinter for 250,000 shares, Yves Gougoux for 500,000 shares, Jan Pretzel for 500,000 shares, Jocelyne Lafreniere for 500,000 shares, Francesco Ferlaino for 750,000 shares, and Prakash Hariharan for 650,000 shares. The company paid a finders' fees of CAD 175,190 with respect to the transaction, CAD 102,600 to Michael Sobolewski, CAD 49,840 to HB Investments & Finance AG, and CAD 22,750 to Cannacord Genuity Corp.
Reported Earnings • Mar 02Third quarter 2021 earnings released: CA$0.034 loss per share (vs CA$0.02 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: CA$1.81m (down 84% from 3Q 2020). Net loss: CA$11.2m (loss widened 106% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.
お知らせ • Feb 05Radient Technologies Inc. Announces Executive ChangesRadient Technologies Inc. announced the appointment of Harry Kaura as the CEO of the Company effective Feb. 03, 2021. Harry is an Edmonton based hands on entrepreneur, with vast experience in operations and business development through his firm Amnor Corporation. He has over three decades of experience as a hands-on operator and fully capable to lead Radient into its new path as a profitable operating business. As Harry has served as a Director in Radient's Board since 2013 and dedicated the past five months in the Business Development initiatives and the management of the operations for Radient. He led the team in Radient in the reorganization of the manufacturing unit that is in full ramp up mode since January 2021. While Jan Petzel will hand over his role as interim CEO of Radient, he will continue to serve the business in an active advisory role to in support Harry Kaura and the team. Jan has been instrumental in leading the transformation of the Company towards a path to operating profitability in calendar 2021.
Reported Earnings • Dec 02Second quarter 2021 earnings released: CA$0.011 loss per shareThe company reported a soft second quarter result with weaker revenues and control over expenses, though losses reduced. Second quarter 2021 results: Revenue: CA$102.7k (down 92% from 2Q 2020). Net loss: CA$3.41m (loss narrowed 51% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 65% per year, which means it is performing significantly worse than earnings.
お知らせ • Nov 28Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis ProductsRadient Technologies Inc. announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences. A human sensory panel is an extremely valuable tool to include in product development and quality programs. It will now form an integral part of Radient's R&D and product development and innovation activities by including the ability to evaluate cannabis extracts, concentrates, edibles and topicals for reactions of human subjects to the smell, sight, taste and touch at the product development stage. This new tool will improve the inherent quality of cannabis product offerings by complementing the stringent internal manufacturing quality systems currently in place, ensuring that all products continue to meet consumers' expectations. This is in addition to Radient's proprietary MAP continuous extraction process that has proven to generate high recoveries (> 95%) of active compounds from the cannabis plant.
お知らせ • Nov 26Radient Technologies Announces Partnership with Dreamy CBDRadient Technologies Inc. announced a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with a positive lifestyle in the rapidly growing Wellness space. The Dreamy CBD products comprise CBD tinctures, CBD distillates, CBD edibles, CBD cosmetics, and CBD Vape Cartridges geared towards the recreational and medical cannabis market. Under this partnership, Radient will have exclusive rights to the licenses and trademarks for Dreamy CBD brands and will collaborate jointly with Dreamy to produce their CBD products and launch their brands in Canada. Radient will be involved in providing the processing facilities in Edmonton and the necessary infrastructure to extract CBD products for Dreamy CBD. In addition, through its Sales License and associated registrations in the provinces, Radient will look to build the Dreamy CBD product portfolio in Canada. On the international front, Radient will produce their CBD based products for markets in Thailand and Japan that are witnessing a strong surge in CBD products consumption, especially in the Wellness space. This will be after completing a comprehensive review of the trade requirements with local partners in these jurisdictions. The partnership is being set initially for a two-year term with an annual renewable option, with Radient reserving the right of first refusal to acquire Dreamy.
Reported Earnings • Oct 10First quarter earnings releasedOver the last 12 months the company has reported total losses of CA$36.5m, with losses widening by 19% from the prior year. Total revenue was CA$18.4m over the last 12 months, up by CA$18.2m from the prior year.
お知らせ • Sep 19+ 1 more updateRadient Technologies Inc. Announces Management ChangesThe board of Radient Technologies Inc. named Jan Petzel as Interim President, effective immediately. Mr. Petzel has been a Director of the Radient since 2016 and has a comprehensive understanding of the company, and a pragmatic view of the priorities that need to be addressed. Jan was a managing director in the Merchant Banking Division of Goldman Sachs, ultimately responsible for private credit in Germany and Scandinavia. While at Goldman Sachs, Mr. Petzel served on the board of several successful companies including Cognis GmbH, a worldwide supplier of specialty chemicals and nutritional ingredients, up to its sale to BASF for €3.1 billion in 2010. The company also announced that Denis Taschuk will step down as president and director of the company, effectively immediately, for family reasons. He will continue as advisor to the Board to facilitate the transition to a new chief executive officer. Denis has been instrumental in leading Radient to become a significant company in the cannabis industry, and the Board wishes to thank Denis for his contribution and tireless efforts over the last 10 years. The company also announced that Mike Cabigon will step down as chief operating officer and director of the company, effective immediately, to pursue other interests. Mike was instrumental in the company’s pivot into the cannabis industry in 2016, and the Board thanks him for all his contribution over the years and wishes him well in his future endeavors.
お知らせ • Sep 17Radient Technologies Inc. Auditor Raises 'Going Concern' DoubtRadient Technologies Inc. filed its Annual on Sep 14, 2020 for the period ending Mar 31, 2020. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
